EPO and nervous system disorder: Especially in neurological disorders, a previous study indicated ARA290 (30 μg/kg, bid) exhibited neuroprotective activities comparable to those of EPO in mild traumatic brain injury (mTBI) followed by hemorrhagic shock.18